Cannabis Briefing

Nearly ten years after medical cannabis became reimbursable under Germany’s statutory health insurance system in 2017, access for seriously ill…

Nearly ten years after medical cannabis became reimbursable under Germany’s statutory health insurance system in 2017, access for seriously ill…

We attended ICBC Berlin this week, the largest international business trade show in the cannabis industry. Pharmacies, wholesalers, manufacturers,…

Medicinal cannabis has been part of routine medical care in Germany since 2017. The available evidence from real-world care data and international…

Medical cannabis in Germany is prescribed in a variety of dosage forms. These range from cannabis flower to standardized extracts and approved…

One year ago, we looked at the role of telemedicine in the context of medical cannabis. Since then, the debate has gained momentum. At its core lies…

When cannabis regulation is discussed in Germany, attention almost inevitably turns across the Atlantic. For years, the United States has served as a…

Trade fairs, conferences and specialist events will once again bring together policymakers, medical professionals, industry representatives and…

As 2026 begins, cannabis regulation in Germany is entering its next phase. After a year of hands-on experience with the Cannabis Act, initial…

As the year draws to a close, it is worth taking a look back at the developments that shaped cannabis policy in Germany in 2025. The new Cannabis Act…

The reform of Germany’s medical cannabis system has been on the agenda since the summer. While the debate has so far focused primarily on new hurdles…

With the upcoming Bundesrat session on 21 November, the legislative process to amend the Medical Cannabis Act (MedCanG) enters a new phase. While the…

Opioids are effective – and risky. They relieve pain, but can also lead to dependence, respiratory depression, and in the worst case, death. This is…

Anyone ensuring that patients across Germany receive their medical cannabis on time works in what is likely the country’s largest medical cannabis…

Yesterday, the German federal cabinet approved the draft bill to amend the Medical Cannabis Act (MedCanG) – despite continued criticism from industry…

Soon, the first results of the evaluation of the Cannabis Act will be published. What developments they will show remains open. Until then, current…

Switzerland is making noticeable progress on cannabis legalization. In one of our earlier editions, we reported that a government report was expected…

In this issue, we dive a little deeper into regulatory specifics: the GACP guidelines. For many in the industry, they are a familiar framework; for…

Today, we want to use our newsletter for the first time to share a very personal message: We have been nominated for the Pioneer Award 2025 in the…

The current draft bill to amend the Medical Cannabis Act (MedCanG) has sparked debate within the cannabis industry. What exactly does this first step…

Medical cannabis is creating waves across Europe—from regulatory advances to controversial setbacks. We have summarized the latest developments from…

In today's edition of the Cannabis Briefing, we speak with Antonia Menzel, who has been the Chairwoman of the Federal Association of Pharmaceutical…

Every year, the Mary Jane Expo in Berlin draws cannabis enthusiasts from all over Europe. From June 19 to 22, 2025, Europe’s largest cannabis trade…

Germany’s new federal government is in place, ministries and committees have been staffed, and now the question is: which way will the country’s…

Medical cannabis is already an evidence-based therapy firmly established for conditions such as chronic pain and spasticity. Of course, additional…

As Germany’s new federal government continues to organize itself, it's worth looking across the border. Elsewhere in Europe, things are moving — not…

A year ago, Germany’s new cannabis law came into effect—more than just a so-called “legalization.” It marked the decriminalization of recreational…

Last week, the German Pain and Palliative Care Days 2025 took place in Frankfurt. Among the numerous lectures and workshops, the use of cannabinoids…

The Endocannabinoid System (ECS) is one of the most fascinating yet least understood systems in the human body. It regulates numerous physiological…

Which cannabis events should you not miss in 2025? From ICBC Berlin and Spannabis to MJBizCon in Las Vegas – get an overview of the most important…

A Step Forward: Easier Access to Medical Cannabis Since the legal changes in spring 2024, medical cannabis can now be prescribed with significantly…

Cannabis research in Germany: Discover why cannabis studies are crucial, which cities are participating, and how scientific data paves the way for…

The year 2024 has been a milestone for the cannabis industry in Germany. The removal of medical cannabis from the Narcotics Act and the launch of…

Is Germany's medical cannabis market booming or heading toward consolidation? Discover the latest Cannabis Briefing for insights into the…

Cansativa’s "Yes, We Can Cannabizz" event in Berlin brought together industry leaders, medical experts, and patients to discuss the future of…

Research lies at the heart of advancements in cannabis and medical cannabis. Thorough scientific studies not only enhance therapeutic understanding…

In today’s Cannabis Briefing, we look beyond our usual scope and explain why the US elections hold international significance, particularly for…

Last year, Switzerland launched its first pilot projects to study the recreational use of cannabis. In today’s edition of the Cannabis Briefing, we…

While Germany has taken the bold step of decriminalizing cannabis for recreational purposes, signaling a major shift in European drug policy, its…

Excitement is widespread in the medical cannabis community and among patients. On July 18, the Federal Joint Committee (Gemeinsamer Bundesausschuss…

It's been 100 days since cannabis was decriminalized in Germany, and the landscape is evolving rapidly. As of this month, cultivation clubs in…

In this edition of our Cannabis Briefing, we explore a development that promises to reshape the landscape of medical cannabis across Europe—not…

In today’s edition of The Cannabis Briefing, we delve deeper into the current challenges and developments in the realm of medicinal cannabis. We had…

As summer draws near, the season of events is just beginning. Continuing our tradition from the last two years, this issue highlights a selection of…

Our readers are well-versed in the societal discourse surrounding cannabis and its legal frameworks. The emotional intensity of the debate persists,…

The recently enacted Cannabis Law marks a significant milestone in German drug policy. However, as soon as the law was passed, the focus swiftly…

After an intensive legislative process, the first Cannabis Act is facing its last major hurdle: vote in the Bundesrat (Federal Council) on March…

After an intensive legislative process, the first Cannabis Act is facing its last major hurdle: vote in the Bundesrat (Federal Council) on March…

After an intensive legislative process, the first Cannabis Act is facing its last major hurdle: vote in the Bundesrat (Federal Council) on March…

Medical cannabis is often used in patients with pain when other therapy options are no longer effective. This is frequently the case with chronic…